Gompel A, Santen RJ. Hormone therapy and breast cancer risk 10 years after the WHI. Climacteric 2012;15:241-9Gompel A, Santen RJ (2012) Hormone therapy and breast cancer risk 10 years after the WHI . Climacteric 15 : 241–249Gompel A, Santen RJ. Hormone therapy and breast cancer risk ...
Most researchers have assumed it takes five years of combined-hormone therapy before the overall risk of developing breast cancer is elevated significantly. But the new study found women who took estrogen and progestin every day for as few as three years were about three times more likely to dev...
Hormone therapy and breast cancer risk There have been longstanding questions about whether hormone therapy—including progestogens and estrogen together or estrogen alone—puts women at increased risk of breast cancer. The waters have been muddied by sometimes conflicting results from large observational ...
Postmenopausal Hormone Therapy and Breast Cancer Risk: Current Status and Unanswered Questions Wendy,Y.,Chen - 《Endocrinology & Metabolism Clinics of North America》 被引量: 22发表: 2011年 Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. Cardiovascular ...
The association between oral contraceptive (OC) use, hormone replacement therapy (HRT) and lung cancer risk in women is still debated. We performed a pooled analysis of six case–control studies (1961 cases and 2609 controls) contributing to the Internat
Objectives: Postmenopausal hormone therapy (PMH) has been widely used by menopausal women living in western countries for the past several decades. Numerous studies have evaluated the relationship between PMH and breast cancer risk because steroid hormones have been implicated in breast cancer etiology....
Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening There is concern that hormone replacement therapy (HRT) increases the risk of breast cancer. We undertook a case-control study of this risk relationship ...
(2001). "Breast cancer and hormone replacement therapy: putting the risk into perspective." Gynecol Endocrinol 15 Suppl 6: 53-60.Campagnoli C, Abba C, Ambroggio S, Biglia N, Ponzone R. Breast cancer and hormone replacement therapy: putting the risk into perspective. Gynecol Endocrinol 2001;...
Ever since the release of the results of the Women’s Health Initiative studies, which were conducted in the 1990s, there has been a reduction in the use of hormone replacement therapy by women. The estrogen plus progesterone study found an increased risk of breast cancer...
Hormone therapy is the treatment of choice for the Lambrinoudaki - 《Maturitas International Journal for the Study of the Climacteric》 被引量: 0发表: 2014年 Hormone replacement therapy and the risk of breast cancer Hormone replacement therapy (HRT) is given to relieve the climacteric symptoms of...